Phillip Andrew Dennis, Chief Medical Officer: NovaBridge Biosciences NBP Sell · Filed 06/22

Trade details

Type: Insider sale
Amount: $5,606.04
Shares · price: 8,494 sh · $0.66 a share
Held after: 157,941 sh
Stock: NovaBridge Biosciences NBP
Person: Phillip Andrew DennisChief Medical Officer
Trade date: 26/06/18
Filed: 26/06/22
Days to filing: 4 days

Sold 5.1% of holdings

Share of holding sold: 5.1%

NovaBridge Biosciences trades, last 26 weeks

What else happened in NovaBridge Biosciences around then

Filed or reported within 30 days of the trade day · 05/19~07/18

Phillip Andrew Dennis's recent trades

Phillip Andrew DennisChief Medical Officer
Planned saleNovaBridge Biosciences
Planned sale
NovaBridge Biosciences
NBP
$5,799
3,569 sh
$5,799
Filed 09/18
Traded 09/18
Phillip Andrew DennisChief Medical Officer
Planned saleNovaBridge Biosciences
Planned sale
NovaBridge Biosciences
NBP
$10.2K
3,638 sh
$10.2K
Filed 03/18
Traded 03/18
Phillip Andrew DennisChief Medical Officer
Planned saleNovaBridge Biosciences
Planned sale
NovaBridge Biosciences
NBP
$14.5K
3,431 sh
$14.5K
Filed 25/12/18
Traded 25/12/18

Phillip Andrew Dennis, Chief Officer — sold $5,606 of NovaBridge Biosciences NBP · 5.1% of holdings | Whalegun